Severe dysphagia due to a huge epiphrenic diverticulum: long-term treatment with balloon dilation and botulinum toxin injection: a case report by Katsinelos, Panagiotis et al.
Case report
Open Access
Severe dysphagia due to a huge epiphrenic diverticulum:
long-term treatment with balloon dilation and
botulinum toxin injection: a case report
Panagiotis Katsinelos, Grigoris Chatzimavroudis*, Kostas Fasoulas,
Ioannis Pilpilidis, Georgia Lazaraki, Taxiarchis Katsinelos, Dimitris Tzilves,
George Germanidis and Themistoklis Vasiliadis
Address: Department of Endoscopy and Motility Unit, “G. Gennimatas” General Hospital of Thessaloniki, Ethnikis Aminis 41, Thessaloniki, Greece
Email: GC* - gchatzimav@yahoo.gr
*Corresponding author
Received: 20 January 2009 Accepted: 9 March 2009 Published: 11 June 2009
Cases Journal 2009, 2:7418 doi: 10.4076/1757-1626-2-7418
This article is available from: http://casesjournal.com/casesjournal/article/view/7418
© 2009 Katsinelos et al; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
We herein describe the first case of a high elderly patient with severe dysphagia in solids and liquids,
caused by a huge epiphrenic diverticulum, who was treated with combined therapy of balloon dilation
and botulinum toxin injection. Due to comorbid associated diseases the patient was unsuitable to
withstand surgical or laparoscopic intervention. Treatment with botulinum toxin injection at the
region of lower esophageal sphincter was unsuccessful. Combined therapy with balloon dilatation and
botulinum toxin injection at the compressed part of esophageal lumen by the diverticulum resulted in
improvement in dysphagia and malnutrition. During the long-term follow-up the patient developed
symptomatic relapses, successfully treated by subsequent combined therapy resulting in longer-lasting
symptom relief.
Introduction
Epiphrenic diverticula (ED) are typically located 4 to 8 cm
above the cardia, comprising about 10% of all esophageal
diverticula [1]. They usually project from the right poster-
ior wall of the esophagus and may be single or multiple.
Despite ED are usually asymptomatic, especially when
they are small, the enlargement of their size can produce
symptoms such as dysphagia, regurgitation of undigested
food, retrosternal discomfort, halitosis, and weight loss
[1,2]. Reported complications include the occurrence of
squamous cell carcinoma within the diverticula, hemor-
rhage, food impaction, bezoars formation and esophageal
lumen obstruction [1-4].
We herein present the first case of a high elderly patient
with severe dysphagia in solids and liquids, caused by a
huge epiphrenic diverticulum, who was unsuitable for
surgery due to comorbid diseases and who was treated
with combined therapy of balloon dilation and botuli-
num toxin (BTX) injection.
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An 88-year-old man with chronic obstructive pulmonary
disease and heart failure was referred to our department
because he presented severe dysphagia in solid and liquid
food during the last 6 months, leading to malnutrition.
Clinical examination revealed an emaciated man. Labora-
tory data showed Hb of 11.3 g/dl (normal range: 13.5-16).
Ht of 30% (normal range: 40-48%), serum albumin of
1.9 g/dl (normal range: 3.5-5) and normal liver and renal
biochemistry. Esophagogram demonstrated a huge epi-
phrenic diverticulum in the posterior-lateral wall. Upper
gastrointestinal endoscopy disclosed food debris and
fluids in the esophagus. After aspiration of fluids and
removal of food debris, a huge diverticulum associated
withstagnation’s esophagitis was demonstrated(Figure1).
The lumen of the esophagus was compressed by the
diverticulum, resulting in obstruction and dysphagia.
Esophageal manometry revealed findings of non-specific
motility disorder.
Due to patient’s associated comorbid diseases and poor
general condition, surgical or laparoscopic treatment was
considered unsuitable. We tried to treat the patient with
BTX injection (100 IU) in the lower esophageal sphincter,
with unsuccessful results. Endoscopic treatment that
would combine balloon dilation of compressed by the
diverticulum esophageal lumen with simultaneous BTX
(100 IU) injection in the proximal aspects of narrowest
area of esophageal lumen was considered as an alternative
treatment that could be applied in this high-risk patient.
After an extensive discussion with patient’s relatives about
benefits and complications of our suggested treatment, a
consent form was signed by them. We dilated the
compressed by the diverticulum esophageal lumen
(Figure 2) with a through-the-scope balloon dilator
(diameter 25 mm, Microvasive, Boston Scientific, USA).
The duration of dilation was 1 min and was repeated three
times. The dilation was followed by BTX injection. BTX of
100 IU (Botox, Merc, Frankfurt, Germany) was dissolved
in 4 ml of normal saline (25 IU/ml) immediately before
injection. Injections (1 ml each) via a sclerotherapy needle
were introduced in the anterior, posterior and lateral parts
of the proximal narrowest area of esophageal lumen
(Figure 3). The patient showed a remarkable relief of his
dysphagia since the first post-procedure week, resulting in
weight gain and gradual improvement of walking. The
beneficial effect of combined therapy lasted 8 weeks and
thereafter the therapy was repeated every 6 to 8 months
during last 28 months with very good results.
Discussion
Surgical or laparoscopic diverticulectomy combined with
long esophagomyotomy is considered the treatment of
Figure 1. Endoscopic view of a huge epiphrenic diverticulum
associated with stagnation esophagitis.
Figure 2. Endoscopic view showing the dilation of the
compressed, by the diverticulum, esophageal lumen.
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However, for elderly patients with comorbid conditions,
such as our patient, surgical or even laparoscopic inter-
vention is associated with significant morbidity and
mortality. As a consequence we preferred to start treatment
with BTX injection in the lower esophageal sphincter.
Despite BTX injection has been widely used in the
treatment of achalasia [7], the reported role of the use of
BTX in other dyskinetic diseases of the esophagus, such as
diffuse esophageal spasm, isolated LES hypertension,
dysphagia due to esophageal diverticula and other specific
esophageal disorders, is very limited [8,9].
There are only 3 reports on the use of BTX injection to
resolve dysphagia due to midesophageal or epiphrenic
diverticula. DeVault injected 80 IU (1 ml of 20 IU)
through a 5 mm sclerotherapy needle into each of the four
quadrants of the proximal aspect of the narrowed area
distal to the diverticulum [10]. All 3 patients with
midesophageal diverticula had remarkable improvement
in their swallowing and remained in remission at 6-month
follow-up examination. Unfortunately, there is no infor-
mation on the long-term course of these patients.
Pitchford and Price described a 75-year-old man with
symptomatic epiphrenic diverticulum in whom they
injected 100 IU of BTX into the LES, providing complete
symptomatic relief [11]. Ten months later, however, the
patient presented again with recurrent symptoms and
underwent epiphrenic diverticulectomy. In a recent
published paper we have described two elderly patients
with dysphagia caused by large epiphrenic diverticula who
were treated with BTX injected endoscopically at multiple
sites in the region of the lower esophageal sphincter and
esophageal wall near to the diverticulum, because they
were unable to withstand surgical or laparoscopic inter-
vention due to severe associated comorbid diseases [12].
Symptoms improved immediately and the beneficial effect
of BTX remained for 5-6 months. During the long-term
follow-up the patient developed symptomatic relapses,
treated by subsequent BTX re-injections resulting in
longer-lasting symptom relief.
In the patient described herein the initial use of BTX
injection (100 IU) in the lower esophageal sphincter was
not associated with symptom’s relief. Our dilemma was to
proceed to gastrostomy, enteral feeding, or to try an
endoscopic treatment which combined the balloon dila-
tion of compressed by the diverticulum esophageal lumen
with simultaneous BTX (100 IU) injection in the proximal
aspects of narrowest area of esophageal lumen. The relief
of symptoms justified our therapeutic choice.
Conclusions
Combined treatment of BTX injection and balloon
dilation of the narrowest area of the esophagus is a
simple, safe and effective method, alternative to surgery,
for high elderly patients with dysphagia due to ED and
severe comorbid diseases.
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Figure 3. The presence of blood is due to BTX injection.
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